JW Asset Management’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-426,903
| Closed | -$3.71M | – | 21 |
|
|
2018
Q2 | $3.71M | Hold |
426,903
| – | – | 2.37% | 10 |
|
|
2018
Q1 | $4.33M | Hold |
426,903
| – | – | 4.27% | 4 |
|
|
2017
Q4 | $2.07M | Hold |
426,903
| – | – | 2.2% | 12 |
|
|
2017
Q3 | $2.16M | Hold |
426,903
| – | – | 1.58% | 15 |
|
|
2017
Q2 | $2.16M | Buy |
426,903
+38,771
| +10% | +$173K | 1.37% | 16 |
|
|
2017
Q1 | $1.84M | Buy |
388,132
+59,999
| +18% | +$303K | 0.38% | 21 |
|
|
2016
Q4 | $1.84M | Buy |
328,133
+1
| +0% | +$5 | 1.22% | 19 |
|
|
2016
Q3 | $1.82M | Hold |
328,132
| – | – | 1.25% | 16 |
|
|
2016
Q2 | $2.3M | Hold |
328,132
| – | – | 1.83% | 13 |
|
|
2016
Q1 | $2.17M | Hold |
328,132
| – | – | 1.42% | 18 |
|
|
2015
Q4 | $3.38M | Sell |
328,132
-153,327
| -32% | -$1.78M | 1.26% | 17 |
|
|
2015
Q3 | $5.67M | Sell |
481,459
-16,562
| -3% | -$183K | 2.05% | 13 |
|
|
2015
Q2 | $4.56M | Sell |
498,021
-746
| -0.1% | -$5.63K | 1.39% | 16 |
|
|
2015
Q1 | $3.1M | Buy |
498,767
+93,411
| +23% | +$578K | 1.34% | 19 |
|
|
2014
Q4 | $2.27M | Buy |
+405,356
| New | +$2.36M | 1.7% | 14 |
|
JW Asset Management's JNP Position: Q3 2018 in Review
JW Asset Management sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 426,903 shares — an estimated $3.71M sold.
JW Asset Management first reported a position in JNP in Q4 2014 and held it in 15 quarters. The position peaked at $5.67M in Q3 2015. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.
- JW Asset Management reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
- JW Asset Management sold 426,903 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $3.71M.
- JW Asset Management first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q4 2014 and held it in 15 quarters.
- JW Asset Management's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $5.67M in Q3 2015.
- 0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.
Based on JW Asset Management's 13F filing for Q3 2018, filed 9 Nov 2018.